Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Libraria Inc.

Latest From Libraria Inc.

Libraria Inc.

Libraria Inc. is using computational techniques to discover new small-molecule drugs that can be administered orally. Its proprietary technology enables the company and its partners to leverage known molecular structures, chemistry protocols, and bioactivity data to speed the chemistry phase of drug discovery by up to 50%.
BioPharmaceutical Research and Development Strategies

Computational Drug Discovery

Computational drug discovery companies promise to unite data from many of the disparate steps pharmaceutical companies go through these days, to enable more efficient lead identification, optimization, and testing.

Start-Up Previews (1/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Computational Drug Discovery, features profiles of Libraria Inc., Plexus Vaccine Inc. and ReceptorBase Inc. Plus these Start-Ups across Health Care: Avalon Pharmaceuticals Inc., CeMines, Octagon Research Solutions Inc. and Renal Solutions Inc.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Libraria Inc.
  • Senior Management
  • Peter Myers, PhD, CEO
    Barry Bunin, PhD, Pres. & CSO
    Robert Reed, PhD, CBO
  • Contact Info
  • Libraria Inc.
    Phone: (408) 383-0790
    2372 Qume Dr.
    Ste. D
    San Jose, CA 95131-1843